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JMC’S Interdisciplinary Smoking Cessation Program 
Tobacco smoking is the leading cause of preventable death in the United States, 
accounting for more than 400,000 deaths per year.1 This is an astounding figure, 
equivalent to three 747 airliner crashes per day, each day for the entire year. 
Despite these risks, the prevalence of smoking remains quite high, with 
approximately 25% of the adult US population currently smoking cigarettes.2 Of all 
of the attributable smoking related diseases, lung cancer remains one of the leading 
sources of major morbidity and mortality within the population, and a significant 
source of healthcare resource expenditure, especially among economically 
disadvantaged cohorts.3 Such sobering statistics belie the fact that about 70% of 
smokers express a desire to quit, and 50% make some attempt at cessation 
annually.4 Yet long term success remains elusive for the vast majority of smokers. 
 
In order to significantly improve these dismal rates, a successful smoking cessation 
intervention may require intensive staffing resources, for example, providing patient 
counseling and arranging periodic follow-up visits, resources most primary care 
physicians, the traditional providers of cessation services, may not have at their 
disposal. A seeming contradiction emerges, given that treating a patient for smoking 
cessation is inexpensive, estimated at less than $2,000 per quality adjusted life year 
(QALY) saved.5
Recognizing that nicotine addiction intervention can be an extremely resource 
intensive undertaking; and perceiving significant limitations with commercially 
available cessation programs, several faculty and staff from a number of 
departments and divisions within JMC (The Comprehensive Center for Tobacco 
Research and Treatment) pooled their individual expertise to create an innovative, 
interdisciplinary smoking cessation intervention, the Jefferson Tobacco Intervention 
Program (JeffTIP). JeffTIP, launched in July 1998, was designed to address several 
key elements that are emerging as critical to long term cessation: patient-centered, 
intensive provider interaction and followup, and an interdisciplinary, “one-stop 
shopping” setting that facilitates optimal patient treatment and management. Based 
at Thomas Jefferson University Hospital (TJUH), the program offers a unique 
integration of medical evaluation and management with intensive individual 
psychological counseling, group educational seminars and combination 
pharmacotherapy to create a medical model of addiction treatment. Patient 
education and relapse prevention form the philosophical foundation of the program. 
JeffTIP is open to patients in the community as well as to physician-referrals. JeffTIP 
is designed to offer particularly intensive resources for the most severely addicted 
patients, those who have experienced frequent relapses and who suffer from 
significant co-morbidity.  
 
JeffTIP aims to take the knowledge gleaned about costeffective pharmacologic 
treatments to the next level. The research question in this context becomes how to 
stratify the population into type of smoker (i.e., based on motivational level, severity 
of addiction, psychosocial barriers to success, etc.), and developing the appropriate 
intervention. Multidisciplinary input becomes imperative. The Agency for Health Care 
Policy and Research (AHCPR) has made great strides in removing and reducing 
barriers to effective physician treatment of nicotine addiction through its Smoking 
Cessation Clinical Practice Guideline.6 A successive AHCPR document on designing 
effective nicotine addiction programs is forthcoming. 
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Patients wishing to receive treatment, or physicians wishing to refer a patient can 
call JeffTIP at (215) 955-STOP. Once registered, patients receive a complete 
evaluation. Psychologic and physiologic measurements are taken, such as severity of 
the nicotine dependency, readiness to quit, ability to cope with cravings, past quit 
attempts, etc. A quit strategy is individually tailored, including pharmacologic 
therapy. Patients are then invited to the JeffTIP educational seminar onsite, which 
runs concurrently. Patients visit TJUH weekly for the first six to eight weeks, than are 
followed every few months, for a year. Throughout the initial program period, 
patients receive periodic follow-up visits with the physician and psychologists, and 
receive individual counseling with a nurse practitioner.  Despite the adverse patient 
selection, JeffTIP has experienced an excellent completion rate (approximately 85% 
to date) and has received consistently excellent satisfaction ratings from its patients. 
Clinical outcome data suggest a 63% three-month continuous abstinence rate. 
 
A remaining challenge for the program is that JeffTIP services remain 
unreimbursable for providers; no area insurers directly cover the cost of care. 
Therefore, patients’ access to the service remains limited. However many patients 
are eligible for reimbursement after sustaining the out-of-pocket expense, and 
payment schedules are considered on an as-needed basis. To learn more about 
JeffTIP call (215) 955-STOP, or by searching “Tobacco” on Jefferson’s Web site: 
http://www.jeffersonhealth.org
••• 
 
Currently, the Comprehensive Center for Tobacco Research and Treatment is 
undertaking a number of research studies that examine the basic inheritable risk for 
nicotine dependence. Research to date on the subject suggests that inheritable 
"hard-wiring" plays an important role in determining a person's risk for developing 
dependency behaviors. One Center study that has received national attention 
attempts to shed light on the genetic determinants of severe nicotine dependence by 
identifying the genetic loci responsible for this effect. As the lead organization in this 
multi-center trial, Jefferson's investigators will be responsible for recruiting 400 pairs 
of siblings into the study over the next two years. Research examining the 
relationship between twin sibling smoking status and their environment suggests 
that such an inheritable factor may indeed influence risk for tobacco use. 
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